The Royal Wolverhampton NHS Trust

Running trials

• Not yet recruiting

  Vitiligo Registry for Adults and Children in the UK

  NCT06218082· Source

• Not yet recruiting

  REal World MAIA UK OutcomEs

  NCT07532473· Source

• Not yet recruiting

  variaTIon in Referral Thresholds in the Chronic Lymphocytic LeukaEmia Pathway

  NCT07463976· Source

• Recruiting

  Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma

  NCT07555938· Phase 3· Source

• Recruiting

  A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

  NCT07361510· Phase 3· Source

• Active, not recruiting

  A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

  NCT06671496· Phase 3· Source

• Recruiting

  Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

  NCT06548542· Phase 2· Source

• Active, not recruiting

  Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)

  NCT06564142· Phase 3· Source

• Recruiting

  The Clinical Utility of BioEP in Diagnostic Decision Making in Epilepsy

  NCT06097195· Source

• Active, not recruiting

  Intensive Weight Loss Intervention Versus Usual Care for Adults With Severe and Complex Obesity

  NCT06321458· Source

• Recruiting

  Transforming Ovarian Cancer Diagnostic Pathways

  NCT06129968· Source

• Active, not recruiting

  A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)

  NCT06113471· Phase 3· Source

• Active, not recruiting

  Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

  NCT05701358· Source

• Recruiting

  Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

  NCT04124120· Source

• Active, not recruiting

  Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

  NCT05478304· Source

• Active, not recruiting

  A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

  NCT05476926· Source

• Active, not recruiting

  HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy

  NCT05338970· Phase 3· Source

• Recruiting

  Zn-DDC to Target Hypoxia-NFkappaB-CSCs Pathway in Multiple Myeloma

  NCT04234022· Source

• Recruiting

  Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole

  NCT04965298· Phase 3· Source

• Active, not recruiting

  A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.

  NCT04680052· Phase 3· Source

• Recruiting

  Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

  NCT04045665· Phase 3· Source

• Recruiting

  Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)

  NCT03573089· Source

• Active, not recruiting

  An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial

  NCT03844048· Phase 3· Source

• Active, not recruiting

  A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433

  NCT03345823· Phase 3· Source

• Active, not recruiting

  A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL

  NCT03336333· Phase 3· Source

• Active, not recruiting

  IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients

  NCT01398085· Phase 2/3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Multiple myeloma3 recruiting
• Childhood cancers2 recruiting
• Atrial fibrillation1 recruiting
• Chronic kidney disease1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Coronary artery disease1 recruiting
• Crohn's disease1 recruiting
• Epilepsy1 recruiting
• Idiopathic pulmonary fibrosis1 recruiting
• Lung cancer1 recruiting
• Ovarian cancer1 recruiting
• Stroke1 recruiting
• Vitiligo1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Withdrawn

  A Novel Haemostatic Agent for Robotic Partial Nephrectomy

  NCT07284953· Source

• Completed

  REACH: RWE Retrospective Study to Evaluate Cenobamate Impact on Health Care Resource Utilization

  NCT06922175· Source

• Completed

  Pre-analytical Influences on a Blood Test Study

  NCT05434949· Source

• Completed

  Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)

  NCT05153239· Phase 3· Source

• Terminated

  Study of Magrolimab Versus Placebo in Combination With Venetoclax and Azacitidine in Participants With Acute Myeloid Leukemia

  NCT05079230· Phase 3· Source

• Completed

  Novel Echocardiographic and Invasive Haemodynamic Measurements in the Assessment of Patients Low Flow Low Gradient Aortic Stenosis Undergoing TAVI

  NCT05196815· Source

• Completed

  Perioperative Iron for Colorectal Cancer (PICoC Study)

  NCT05177484· Phase 3· Source

• Completed

  An Observational Study to Assess the Real-World Effectiveness of Upadacitinib in Adult Participants With Rheumatoid Arthritis

  NCT05170646· Source

• Completed

  PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V

  NCT04870333· Phase 2/3· Source

• Completed

  BIOTIPRA: BIOmarker-guided Treatment Decisions In Psoriatic and Rheumatoid Arthritis

  NCT03853395· Source

• Completed

  WORKWELL: Testing Work Advice for People With Arthritis

  NCT03942783· Source

• Completed

  Phase II Randomised Trial of Cyclophosphamide & Dexamethasone in Combination With Ixazomib in Relapsed or Refractory Multiple Myeloma.

  NCT02461888· Phase 2· Source

• Completed

  A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

  NCT01848561· Source

Trial sites

• The Royal Wolverhampton NHS Trust1 trial
• Royal Wolverhampton Nhs Trust1 trial
• Epilepsies - The Royal Wolverhampton NHS Trust1 trial
• Royal Wolverhampton Nhs Trust7 trials
• The Royal Wolverhampton Hospital NHS Trust1 trial
• The Royal Wolverhampton Hospitals NHS Trust2 trials
• The Royal Wolverhampton NHS Trust21 trials
• The Royal Wolverhampton NHS Trust /ID# 1642091 trial
• The Royal Wolverhampton NHS Trust /ID# 1713951 trial
• The Royal Wolverhampton NHS Trust /ID# 2251641 trial
• The Royal Wolverhampton NHS Trust /ID# 2517081 trial
• The Royal Wolverhampton NHS Trust /ID# 2681581 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Vitiligo14 works · 2 trials
• Dermatomyositis and polymyositis (myositis)7 works · 0 trials
• Alopecia areata4 works · 0 trials